APPLIED THERAPEUTICS INC (APLT)
US03828A1016 - Common Stock
APPLIED THERAPEUTICS INC
NASDAQ:APLT (1/8/2025, 8:00:00 PM)
After market: 0.7236 0 (-0.26%)0.7255
-0.08 (-9.54%)
Company Profile
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. The company is headquartered in New York City, New York and currently employs 37 full-time employees. The company went IPO on 2019-05-09. The company is focused on developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of central nervous system (CNS) rare metabolic diseases, including Galactosemia, Sorbitol Dehydrogenase (SORD) Deficiency, and PMM2-CDG. The firm is also developing AT-001, a novel potent ARI, for the treatment of Diabetic Cardiomyopathy (DbCM) a fatal fibrosis of the heart. The company has completed a Phase I/II clinical trial evaluating AT-001 in approximately 120 patients with type 2 diabetes, in which no drug-related adverse effects or tolerability issues were observed. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of Diabetic retinopathy.
Company Info
APPLIED THERAPEUTICS INC
545 Fifth Avenue, Suite 1400
New York City NEW YORK 10017
P: 12122209226
CEO: Shoshana Shendelman
Employees: 31
Website: https://www.appliedtherapeutics.com/
APLT News
13 hours ago - The Gross Law FirmLost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares...
a day ago - Pomerantz LLPSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company")...
a day ago - TheNewswire.comApplied Therapeutics, Inc. (APLT) Investors: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLPRADNOR, PA - January 8, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics”) (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 18, 2025.
a day ago - NewMediaWireApplied Therapeutics, Inc. (APLT) Investors: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLPSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
a day ago - Faruqi & Faruqi, LLPFaruqi & Faruqi Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Applied Therapeutics, Inc. ("Applied...
2 days ago - Bragar Eagel & SquireBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kaspi, Applied Therapeutics, Nextracker, and Transocean and Encourages Investors to Contact the FirmAPLT Twits
Here you can normally see the latest stock twits on APLT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
